Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$15.96M+21.5%$16.08M+18.1%$17.63M+20.5%$15.01M+1.0%$13.14M+0.8%
$6.22M+29.8%$5.44M+143%$5.76M+8.9%$4.94M-24.5%$4.79M-29.7%
$9.74M+16.7%$10.64M-6.5%$11.88M+27.1%$10.07M+21.1%$8.35M+34.4%
61%-2.5pp66.2%-17.4pp67.4%+3.5pp67.1%+11.1pp63.5%+15.9pp
$154K-29.4%$287K-65.9%$0-100%$39K-99.5%
$10.11M-4.4%$9.86M-2.0%$12.05M+5.8%$11.88M+15.0%$10.57M+25.5%
$17.45M+6.0%$16.52M+45.1%$19.16M+9.3%$17.89M+0.6%$16.46M-28.8%
-$1.49M+55.1%-$443K-$1.53M+47.2%-$2.88M+1.7%-$3.32M+67.1%
-9.3%+16.0pp-2.8%-8.7%+11.1pp-19.2%+0.5pp-25.3%+52.1pp
$892K+0.1%$933K+12.3%$937K+23.6%$937K+66.4%$891K+62.6%
-$738K+1.5%-$804K-23.3%-$786K-256%-$860K-98.2%-$749K-113%
-$2.23M+45.2%-$1.25M-$2.32M+3.1%-$3.74M-11.2%-$4.07M+61.0%
-$2.23M+45.2%-$1.25M-$2.32M+3.1%-$3.8M-12.9%-$4.07M+61.0%
-14%+17.0pp-7.8%-13.1%+3.2pp-25.3%-2.7pp-31%+49.1pp
-$0.08+55.6%-$0.04-$0.09+25.0%-$0.16+5.9%-$0.18+66.0%
-$366K+83.8%$622K-$465K+77.6%-$1.81M+14.2%-$2.26M+75.6%
-2.3%+14.9pp3.9%-2.6%+11.6pp-12.1%+2.2pp-17.2%+54.0pp
-$1.49M+55.1%-$443K-$1.53M+47.2%-$2.88M+1.7%-$3.32M+67.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Journey Medical Corporation's revenue?
Journey Medical Corporation (DERM) generated $64.7M in revenue over the trailing twelve months, up 15.0% year over year.
Is Journey Medical Corporation profitable?
Journey Medical Corporation is not currently profitable: it reported a net loss of $9.6M over the trailing twelve months, a -14.8% net margin.
What are Journey Medical Corporation's profit margins?
Gross margin is 65.4% and operating margin is -9.8%, with a -14.8% net margin.
What is Journey Medical Corporation's earnings per share?
Journey Medical Corporation's diluted EPS over the trailing twelve months is $-0.37.
Where does Journey Medical Corporation's income statement data come from?
Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.